NO20001400L - Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonist - Google Patents
Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonistInfo
- Publication number
- NO20001400L NO20001400L NO20001400A NO20001400A NO20001400L NO 20001400 L NO20001400 L NO 20001400L NO 20001400 A NO20001400 A NO 20001400A NO 20001400 A NO20001400 A NO 20001400A NO 20001400 L NO20001400 L NO 20001400L
- Authority
- NO
- Norway
- Prior art keywords
- combination
- monoamine oxidase
- partial agonist
- oxidase inhibitor
- alkyl
- Prior art date
Links
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 239000002899 monoamine oxidase inhibitor Substances 0.000 title abstract 2
- 239000004031 partial agonist Substances 0.000 title abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- -1 C1-Cf Chemical group 0.000 abstract 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 abstract 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9703376A SE9703376D0 (sv) | 1997-09-18 | 1997-09-18 | A new combination |
| PCT/SE1998/001602 WO1999013878A1 (fr) | 1997-09-18 | 1998-09-09 | UNE COMBINAISON D'UN INHIBITEUR DE LA MONOAMINE OXYDAGE ET ANTAGONISTE A h5-HT1B OU AGONISTE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001400D0 NO20001400D0 (no) | 2000-03-17 |
| NO20001400L true NO20001400L (no) | 2000-05-05 |
Family
ID=20408296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001400A NO20001400L (no) | 1997-09-18 | 2000-03-17 | Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonist |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6159970A (fr) |
| EP (1) | EP1014986B1 (fr) |
| JP (1) | JP2001516719A (fr) |
| KR (2) | KR20010024087A (fr) |
| CN (1) | CN1278727A (fr) |
| AR (1) | AR013503A1 (fr) |
| AT (1) | ATE270889T1 (fr) |
| AU (1) | AU752719B2 (fr) |
| BR (1) | BR9812236A (fr) |
| CA (1) | CA2302204A1 (fr) |
| DE (1) | DE69825062T2 (fr) |
| DK (1) | DK1014986T3 (fr) |
| EE (1) | EE200000146A (fr) |
| ES (1) | ES2222603T3 (fr) |
| HU (1) | HUP0100621A2 (fr) |
| ID (1) | ID25789A (fr) |
| IL (1) | IL134775A0 (fr) |
| IS (1) | IS5401A (fr) |
| MX (1) | MXPA00002616A (fr) |
| NO (1) | NO20001400L (fr) |
| PL (1) | PL339368A1 (fr) |
| PT (1) | PT1014986E (fr) |
| SE (1) | SE9703376D0 (fr) |
| SK (1) | SK2832000A3 (fr) |
| TR (1) | TR200000725T2 (fr) |
| WO (1) | WO1999013878A1 (fr) |
| ZA (1) | ZA987804B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4957948A (en) * | 1988-05-05 | 1990-09-18 | Interface, Inc. | Biocidal protective coating for heat exchanger coils |
| SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| WO2002066454A1 (fr) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Derives de chromene |
| ES2323451T7 (es) * | 2001-07-20 | 2011-08-01 | Psychogenics Inc. | Tratamiento para el trastorno de hiperactividad con deficit de atencion. |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| JP2009533325A (ja) * | 2006-03-17 | 2009-09-17 | アストラゼネカ・アクチエボラーグ | ５−ｈｔ６調節剤としての新規なテトラリン |
| US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| JP5930573B2 (ja) | 2007-03-01 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤の新規使用 |
| EP2142514B1 (fr) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Dérivés de thio-urée utilisés comme inhibiteurs de la glutaminyl cyclase |
| JP5934645B2 (ja) | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| NZ602312A (en) | 2010-03-10 | 2014-02-28 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| WO2011131748A2 (fr) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Nouveaux inhibiteurs |
| EP2686313B1 (fr) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Dérivés de benzimidazole en tant qu'inhibiteurs de la glutaminyl cyclase |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| WO2020183011A1 (fr) | 2019-03-14 | 2020-09-17 | Institut Curie | Inhibiteurs de htr1d et leurs utilisations dans le traitement du cancer |
| CN110179988A (zh) * | 2019-07-10 | 2019-08-30 | 王大伟 | 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用 |
| IL321485A (en) * | 2022-12-14 | 2025-08-01 | Luminous Mind Inc | Treatment of psychological symptoms affecting other medical conditions (PFAOMC) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT533268E (pt) * | 1991-09-18 | 2002-02-28 | Glaxo Group Ltd | Derivados de benzanilida como antagonistas de 5-ht1d |
| GB9119932D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
-
1997
- 1997-09-18 SE SE9703376A patent/SE9703376D0/xx unknown
-
1998
- 1998-08-27 ZA ZA987804A patent/ZA987804B/xx unknown
- 1998-09-09 US US09/171,578 patent/US6159970A/en not_active Expired - Fee Related
- 1998-09-09 CA CA002302204A patent/CA2302204A1/fr not_active Abandoned
- 1998-09-09 BR BR9812236-3A patent/BR9812236A/pt not_active IP Right Cessation
- 1998-09-09 PT PT98944376T patent/PT1014986E/pt unknown
- 1998-09-09 PL PL98339368A patent/PL339368A1/xx unknown
- 1998-09-09 IL IL13477598A patent/IL134775A0/xx unknown
- 1998-09-09 CN CN98811114A patent/CN1278727A/zh active Pending
- 1998-09-09 AT AT98944376T patent/ATE270889T1/de not_active IP Right Cessation
- 1998-09-09 DE DE69825062T patent/DE69825062T2/de not_active Expired - Fee Related
- 1998-09-09 EE EEP200000146A patent/EE200000146A/xx unknown
- 1998-09-09 HU HU0100621A patent/HUP0100621A2/hu unknown
- 1998-09-09 SK SK283-2000A patent/SK2832000A3/sk unknown
- 1998-09-09 KR KR1020007002835A patent/KR20010024087A/ko not_active Ceased
- 1998-09-09 WO PCT/SE1998/001602 patent/WO1999013878A1/fr not_active Ceased
- 1998-09-09 AU AU91931/98A patent/AU752719B2/en not_active Ceased
- 1998-09-09 KR KR1020007002830A patent/KR20010024084A/ko not_active Withdrawn
- 1998-09-09 DK DK98944376T patent/DK1014986T3/da active
- 1998-09-09 EP EP98944376A patent/EP1014986B1/fr not_active Expired - Lifetime
- 1998-09-09 MX MXPA00002616A patent/MXPA00002616A/es unknown
- 1998-09-09 ID IDW20000522D patent/ID25789A/id unknown
- 1998-09-09 JP JP2000511500A patent/JP2001516719A/ja active Pending
- 1998-09-09 ES ES98944376T patent/ES2222603T3/es not_active Expired - Lifetime
- 1998-09-09 TR TR2000/00725T patent/TR200000725T2/xx unknown
- 1998-09-17 AR ARP980104635A patent/AR013503A1/es unknown
-
2000
- 2000-03-14 IS IS5401A patent/IS5401A/is unknown
- 2000-03-17 NO NO20001400A patent/NO20001400L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL134775A0 (en) | 2001-04-30 |
| MXPA00002616A (es) | 2002-04-24 |
| TR200000725T2 (tr) | 2000-08-21 |
| PT1014986E (pt) | 2004-10-29 |
| DK1014986T3 (da) | 2004-10-25 |
| PL339368A1 (en) | 2000-12-18 |
| AR013503A1 (es) | 2000-12-27 |
| EE200000146A (et) | 2001-02-15 |
| DE69825062D1 (de) | 2004-08-19 |
| ES2222603T3 (es) | 2005-02-01 |
| KR20010024084A (ko) | 2001-03-26 |
| AU752719B2 (en) | 2002-09-26 |
| ATE270889T1 (de) | 2004-07-15 |
| CN1278727A (zh) | 2001-01-03 |
| ID25789A (id) | 2000-11-02 |
| KR20010024087A (ko) | 2001-03-26 |
| IS5401A (is) | 2000-03-14 |
| EP1014986B1 (fr) | 2004-07-14 |
| SK2832000A3 (en) | 2000-09-12 |
| SE9703376D0 (sv) | 1997-09-18 |
| ZA987804B (en) | 1999-03-18 |
| EP1014986A1 (fr) | 2000-07-05 |
| HUP0100621A2 (hu) | 2001-08-28 |
| CA2302204A1 (fr) | 1999-03-25 |
| BR9812236A (pt) | 2000-07-18 |
| JP2001516719A (ja) | 2001-10-02 |
| WO1999013878A1 (fr) | 1999-03-25 |
| NO20001400D0 (no) | 2000-03-17 |
| AU9193198A (en) | 1999-04-05 |
| DE69825062T2 (de) | 2005-08-25 |
| US6159970A (en) | 2000-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001400L (no) | Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonist | |
| MY116280A (en) | A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist | |
| NO20025821L (no) | 2-aminokarbonyl-9H-purinderivater | |
| WO2003062259A3 (fr) | Nouveaux composes | |
| NO306237B1 (no) | Anvendelse av xantinderivater som antidepressive midler | |
| WO2001077107A8 (fr) | Production et utilisation de composes heterocycliques | |
| KR930702337A (ko) | 메틸렌-옥스인돌 유도체 및 이의 제조방법 | |
| NO20002121L (no) | Benzotiazol-protein-tyrosin-kinaseinhibitorer | |
| MXPA03008215A (es) | Inhibidores de integrina alfa v beta 6. | |
| NO308248B1 (no) | Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat | |
| BR0314455A (pt) | Derivados de aminoálcool, seus sais e agentes imunosupressores | |
| NO995963D0 (no) | Karboksamider anvendelige som 5-HTIF-agonister | |
| NO951980D0 (no) | Anvendelse av dimetylbenzofuraner og dimetylbenzopyraner som 5-HT -antagonister | |
| FI951631A0 (fi) | Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| DK0861250T3 (da) | Amindin- og isothiourinstofderivater som inhibitorer for nitrogenmonoxidsyntase | |
| WO1995001170A3 (fr) | Utilisation des derives de phenethanolamine dans le traitement des troubles gastro-intestinaux | |
| PL290676A1 (en) | Method of obtaining novel derivatives of 2-aminoalkyl-5-diaryl-alkyl-1.3-dioxane | |
| FI945582A0 (fi) | Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina | |
| NO20023041L (no) | Fremgangsmåte for fremstilling av pyrazolopyridazinderivater | |
| DK1169029T3 (da) | Anvendelse af sibutramin eller et derivat deraf til behandling af sövnforstyrrelser | |
| MY116281A (en) | A combination of a selective 5-ht 1a antagonist and a selective h5-ht 1b antagonist or partial agonist. | |
| DK0906295T3 (da) | Dibenzo-oxazepin- og -dioxepinderivater og deres anvendelse som anti-tumormidler | |
| DK0885004T3 (da) | Anvendelse af 4-phenyl-3,6-dihydro-2H-pyridyl-derivater som NMDA-receptor-undertypeblokkere | |
| TW429147B (en) | Pharmaceutical composition for the treatment of CNS disorders | |
| SE9800835D0 (sv) | New Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |